Helena StrigĂĄrd, NorthX Biologics CEO

Swedish man­u­fac­tur­er ac­quires Val­ne­va fa­cil­i­ty

NorthX Bi­o­log­ics, a cell and gene ther­a­py man­u­fac­tur­ing and de­vel­op­ment out­fit based in Mat­fors, Swe­den, has ac­quired a fa­cil­i­ty from Val­ne­va.

As part of the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.